calmedfoundation.org
calmedfoundation.org / Research and analysis /

30.10.201422725836 Male6226052SARACATINIBSuspectI

30.10.201422725836 Male6226052SARACATINIBSuspectI

30.10.201422725836 Male6226052SARACATINIBSuspectI
06.05.201422528921 FemaleUNKNOWNTACROLIMUSSuspectMOHAMED-AHMED O, NELSON-
01.10.201422709761 BAXTER HEALTHCARE CYCLOPHOSPHAMIDE INJECTION 1G
18.11.20142274587674 YEARSFemale54.9RT035-p1002-02CO-AMOXICLAVConcomitantII
03.04.20142249100758 YEARSUNKNOWNDEFEROXAMINEConcomitantR.
11.03.201422458976 FemaleUNKNOWNPACLITAXELSuspectADHIKAREE J, NEWBY Y, SUNDAR
05.12.2014227869485 YEARS10ETOPOSIDESuspectTHUST SC ET AL. MRI
TRANSPLANTATION. JOURNAL OF HEPATOLOGY 2014;60 (1 SUPPL. 1):S361-S522.
140 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH MULTIPLE MYELOMA. BIOL BLOOD MARROW TRANSPLANT. 2013;19:1453-58.
24.06.20142258786251 YEARSMale97RMGLICLAZIDESuspectNICOLA MILNE.
09.09.20142268288662 YEARSMaleUNKNOWNNITROFURANTOINSuspectWARD PA. IATROGENIC
*nifedipinesustained-release formulations, tablet, 10mg
08.01.20152282370558 YEARSMaleMETHOTREXATESuspectKAZLOW D,FEDERGRUN
28.05.20142255622086 YEARSMaleWARFARINConcomitantCHAPMAN M,
DAVIES RJ, KHAMASHTA MA, DCRUZ DP. B-CELL DEPLETION THERAPY AND PREGNANCY OUTCOME IN SEVERE, REFRACTORY SYSTEMIC AUTOIMMUNE DISEASES. J AUTOIMMUN.
27.10.20142273541745 YEARSUNKNOWNCase-1CISPLATINSuspectGHOSAL N, MAIS K,
26.02.20142244357255 YEARSFemale63.2LMITC25CIPROFLOXACINConcomitantII
17.09.20142269265088 YEARSFemaleOFDISOPYRAMIDEConcomitantTORPEY
05.09.201422679743 Male73.25042ASPIRINConcomitantI
11.04.20142249448970 YEARSMale70.4OBLOPERAMIDEConcomitantIII
DEMPSTER J, LORENZO L, GRIGORIADOU S AND LONGHURST H PRIMARY VS. SECONDARY ANTIBODY DEFICIENCY: CLINICAL FEATURES AND INFECTION OUTCOMES OF
18.06.20142030829127 YEARSMaleUNKLATANOPROSTSuspectSTUMPF TH, AUSTIN M,
09.10.20142270096885 YEARSMale62.9SDINC - 013NYSTATINConcomitantII
HALLUCINATIONS DURING LAMOTRIGINE TREATMENT OF BIPOLAR DISORDER.. AM J PSYCHIATRY 2006 APR;163 (4):749-750.
sulfamethoxazole + trimethoprim (D)tablet, 100mg + 20mg, 400mg + 80mg, 800mg+ 160mg; oral liquid, 200mg + 40mg/5ml; injection, 80mg + 16mg/ml in


Clinical
United States. Colorado


day: 19.01.2015
views - 1245


Show all ads calmedfoundation


photo:

30.10.201422725836 Male6226052SARACATINIBSuspectI


more ads:

18.03.201422469705 FemaleUNKNOWNZOLEDRONIC ACIDSuspectADHIKAREE J, NEWBY Y, SUNDAR
18.03.201422469705 FemaleUNKNOWNZOLEDRONIC ACIDSuspectADHIKAREE J, NEWBY Y, SUNDAR
improving the ...

Lin J S, OConnor E, Whitlock EP, Beil TL (2010) Behavioral counseling to promote physical activity and a healthful diet
Lin J S, OConnor E, Whitlock EP, Beil TL (2010) Behavioral counseling to promote physical activity a ...

23.09.201422698908 FemaleUNKNOWNAZATHIOPRINESuspectBAIN B. PROMINENT HOWELL-
23.09.201422698908 FemaleUNKNOWNAZATHIOPRINESuspectBAIN B. PROMINENT HOWELL-
All plasma fractions ...

06.02.20142241939967 YEARSMale96.2MK00278CYCLOPHOSPHAMIDE ANHYDROUSConcomitant
06.02.20142241939967 YEARSMale96.2MK00278CYCLOPHOSPHAMIDE ANHYDROUSConcomitant
28.04.201422519498 ...

22.12.20142278671849 YEARSFemaleAMOXICILLINSuspectJM WADSWORTH, M
22.12.20142278671849 YEARSFemaleAMOXICILLINSuspectJM WADSWORTH, M
14.05.20142254091419 YEARSFemal ...

01.09.20142267263758 YEARSMaleDOXAZOSINSuspectCHARLOTTE L REDSHAW,
01.09.20142267263758 YEARSMaleDOXAZOSINSuspectCHARLOTTE L REDSHAW,
POLYNEUROPATHY IN A PATIENT RE ...

19.09.2014226957713 YEARSUNKNOWNMENINGOCOCCAL GROUP C CONJUGATESuspectSADARANGANI
19.09.2014226957713 YEARSUNKNOWNMENINGOCOCCAL GROUP C CONJUGATESuspectSADARANGANI
02.07.201422598 ...

03.12.20142278369146 YEARSFemaleHYDROXYCHLOROQUINESuspectFAIN O,FRILAY
03.12.20142278369146 YEARSFemaleHYDROXYCHLOROQUINESuspectFAIN O,FRILAY
08.12.20142278971059 YEARS ...

pharmaceutical analysis Screening and discovery of anti-cancer compunds from natural productsDiscovery of bioactive comp
pharmaceutical analysis Screening and discovery of anti-cancer compunds from natural productsDiscove ...

EW. USE OF TOLVAPTAN IN THE TREATMENT OF SIADH SECONDARY TO SCLC - A CASE SERIES. BRITISH THORACIC ONCOLOGY GROUP (POSTE
EW. USE OF TOLVAPTAN IN THE TREATMENT OF SIADH SECONDARY TO SCLC - A CASE SERIES. BRITISH THORACIC O ...

ads

ads